241 results
Page 10 of 13
8-K
EX-99.1
2uea3ffdpka2ipnr9
9 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
3176dbffnqsj23q
9 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
pglazupevrsm901lgvj
24 Feb 15
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
pb6slsh3n4i
29 Oct 14
Alkermes PLC Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
q9u ojyz782rmzsvq2nn
31 Jul 14
Alkermes PLC Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
bmq ij223y8h9jtv9
8 Apr 14
Alkermes Announces Positive Topline Results from Pivotal Phase 3 Study of Aripiprazole Lauroxil for Treatment of Schizophrenia
12:00am
8-K
EX-99.1
ovps3u409u6hipidt
27 Feb 14
Results of Operations and Financial Condition
12:00am
10-KT
apquqjdiyn1t
27 Feb 14
Annual report (with FYE transition)
12:00am
8-K
EX-99.1
jt4rp1o5iqn
13 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
zrmcdz8tr
8 Jan 14
Alkermes Announces Advances with Its Late-stage CNS Pipeline
12:00am
8-K
EX-99.1
q9icnzpidc9a 2nehd
6 Jan 14
Alkermes Announces Notice of Allowance of U.S. Patent for a Novel Fumarate Prodrug for Multiple Sclerosis
12:00am
8-K
EX-99.1
5nv9wpd20fv7cw1k3
31 Oct 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
dqe7i lwnc6f34
25 Jul 13
Results of Operations and Financial Condition
12:00am